Cas no 93236-42-1 (Cistanoside A)

Cistanoside A is a phenylethanoid glycoside compound primarily isolated from the medicinal plant Cistanche deserticola. It exhibits notable bioactivity, including antioxidant, anti-inflammatory, and neuroprotective properties, making it a subject of interest in pharmaceutical and nutraceutical research. Structurally, it features a phenylethyl moiety linked to a glucose unit, contributing to its stability and bioavailability. Studies suggest potential applications in mitigating oxidative stress and neurodegenerative disorders. Its natural origin and well-characterized pharmacological profile enhance its suitability for preclinical and clinical investigations. Analytical methods such as HPLC and LC-MS are commonly employed for its quantification, ensuring high purity and reproducibility in research applications.
Cistanoside A structure
Cistanoside A structure
Product Name:Cistanoside A
CAS No:93236-42-1
MF:C36H48O20
MW:800.754333496094
CID:61612
PubChem ID:101691130
Update Time:2025-10-31

Cistanoside A Chemical and Physical Properties

Names and Identifiers

    • Cistanoside A
    • [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethoxy]-2-[[(2R,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]o
    • I07-0327
    • β-D-Glucopyranoside, 2-(4-hydroxy-3-methoxyphenyl)ethyl O-6-deoxy-α-L-mannopyranosyl-(1→3)-O-[β-D-glucopyranosyl-(1→6)]-, 4-[3-(3,4-dihydroxyphenyl)-2-propenoate], (E)- (ZCI)
    • D
    • L
    • DTXSID701317669
    • (2R,3R,4R,5R,6R)-5-Hydroxy-6-(4-hydroxy-3-methoxyphenethoxy)-2-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-4-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl (E)-3-(3,4-dihydroxyphenyl)acrylate
    • [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethoxy]-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
    • CS-0007092
    • AS-83354
    • CISTANOSIDEA
    • HY-N0023
    • Desert living Cistanche
    • 93236-42-1
    • Inchi： 1S/C36H48O20/c1-15-25(42)27(44)30(47)36(52-15)56-33-31(48)35(50-10-9-17-4-7-19(39)21(12-17)49-2)54-23(14-51-34-29(46)28(45)26(43)22(13-37)53-34)32(33)55-24(41)8-5-16-3-6-18(38)20(40)11-16/h3-8,11-12,15,22-23,25-40,42-48H,9-10,13-14H2,1-2H3/b8-5+/t15-,22+,23+,25-,26+,27+,28-,29+,30+,31+,32+,33+,34+,35+,36-/m0/s1
    • InChI Key： LOGNFAUMIGACHZ-WEDRDYHSSA-N
    • SMILES： O([C@@H]1[C@@H](CO[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H](OCCC2C=CC(O)=C(OC)C=2)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)/C=C/C1C=CC(O)=C(O)C=1

Computed Properties

  • Exact Mass: 800.27400
  • Monoisotopic Mass: 800.273894
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 11
  • Hydrogen Bond Acceptor Count: 20
  • Heavy Atom Count: 56
  • Rotatable Bond Count: 15
  • Complexity: 1250
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 15
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 1
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 313
  • XLogP3: -1.8

Experimental Properties

  • Color/Form: Powder
  • Density: 1.6±0.1 g/cm3
  • Boiling Point: 1040.1°C at 760 mmHg
  • Flash Point: 318.4±27.8 °C
  • Refractive Index: 1.676
  • PSA: 313.44000
  • LogP: -2.88870
  • Vapor Pressure: 0.0±0.3 mmHg at 25°C

Cistanoside A Security Information

Cistanoside A Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-YM171-10mg
Cistanoside A
 93236-42-1 98+%
10mg
 1732CNY 2021-05-07
MedChemExpress
HY-N0023-5mg
Cistanoside A
 93236-42-1 99.39%
5mg
 ￥829 2025-04-15
MedChemExpress
HY-N0023-10mg
Cistanoside A
 93236-42-1 99.39%
10mg
 ￥1210 2025-04-15
ChemFaces
CFN90526-10mg
Cistanoside A
 93236-42-1 >=98%
10mg
 $188 2021-07-22
ChemScence
CS-0007092-5mg
Cistanoside A
 93236-42-1
5mg
 $269.0 2022-04-26
ChemScence
CS-0007092-10mg
Cistanoside A
 93236-42-1
10mg
 $457.0 2022-04-26
TRC
C499510-1mg
Cistanoside A
 93236-42-1
1mg
 $104.00 2023-05-18
TRC
C499510-2.5mg
Cistanoside A
 93236-42-1
2.5mg
 $201.00 2023-05-18
Chengdu Biopurify Phytochemicals Ltd
BP0371-100mg
Cistanoside A
 93236-42-1 98%
100mg
 $750 2023-09-20
Chengdu Biopurify Phytochemicals Ltd
BP0371-10mg
Cistanoside A
 93236-42-1 98%
10mg
 $135 2023-09-20

Cistanoside A Suppliers

Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
(CAS:93236-42-1)Cistanoside A
Order Number:A1205771
Stock Status:in Stock
Quantity:25mg/50mg/100mg
Purity:99%
Pricing Information Last Updated:Monday, 2 September 2024 15:57
Price ($):201.0/341.0/580.0
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier Audited Supplier
(CAS:93236-42-1)肉蓯蓉苷 A
Order Number:LE1695652
Stock Status:in Stock
Quantity:25KG,200KG,1000KG
Purity:99%
Pricing Information Last Updated:Friday, 20 June 2025 12:34
Price ($):discuss personally

Cistanoside A Related Literature

Related Categories

Additional information on Cistanoside A

Cistanoside A: A Comprehensive Overview of Its Chemistry, Biology, and Therapeutic Potential

Cistanoside A, with the chemical formula C28H32O10 and a CAS number of 93236-42-1, is a naturally occurring glycoside compound that has garnered significant attention in the field of pharmaceutical research and natural product chemistry. This compound is primarily isolated from the seeds of Cistanche salsa, a plant traditionally used in Chinese medicine for its various health benefits. The unique structural features and biological activities of Cistanoside A have positioned it as a promising candidate for further exploration in drug development and therapeutic applications.

The molecular structure of Cistanoside A consists of an aglycone moiety linked to a glucose moiety through a β-glycosidic bond. This structural arrangement contributes to its solubility in water and its stability under physiological conditions, making it an attractive candidate for biological studies. The aglycone part of the molecule contains a steroidal backbone, which is characteristic of many bioactive compounds found in plants. This steroidal core is responsible for many of the pharmacological properties exhibited by Cistanoside A.

Recent research has focused on elucidating the pharmacological mechanisms underlying the effects of Cistanoside A. Studies have demonstrated that this compound exhibits potent anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. These findings are particularly significant given the widespread use of anti-inflammatory drugs in managing chronic inflammatory diseases. Additionally, Cistanoside A has shown promise in preclinical studies as a potential therapeutic agent for neurodegenerative disorders. Its ability to cross the blood-brain barrier and modulate key signaling pathways involved in neuroprotection has made it a subject of intense interest among researchers.

The anti-cancer potential of Cistanoside A is another area that has seen considerable investigation. Preclinical studies have revealed that this compound can induce apoptosis in various cancer cell lines by activating caspase-dependent pathways. Furthermore, it has been shown to inhibit the growth of cancer cells by disrupting microtubule formation, thereby preventing cell division. These effects make Cistanoside A a promising candidate for development into an anti-cancer therapeutic agent. However, further research is needed to fully understand its mechanisms of action and to assess its potential for clinical application.

In addition to its anti-inflammatory, neuroprotective, and anti-cancer properties, Cistanoside A has also been investigated for its cardiovascular benefits. Studies have indicated that this compound can improve endothelial function by enhancing nitric oxide production and reducing oxidative stress. These effects suggest that Cistanoside A may have therapeutic potential in managing cardiovascular diseases such as atherosclerosis and hypertension.

The extraction and isolation of Cistanoside A from plant sources remain a challenge due to its low abundance in the natural habitat. Advanced chromatographic techniques such as high-performance liquid chromatography (HPLC) are commonly employed to purify this compound. Additionally, biotechnological approaches such as cell culture and metabolic engineering are being explored to enhance the yield of Cistanoside A. These efforts are crucial for ensuring a sustainable supply of this valuable compound for future research and commercial applications.

The pharmacokinetic profile of Cistanoside A is another critical aspect that needs further investigation. Initial studies have shown that this compound exhibits moderate bioavailability upon oral administration, with peak plasma concentrations reached within 2-3 hours post-dosing. However, its rapid metabolism and clearance from the body necessitate repeated dosing or alternative delivery systems such as nanoparticles or liposomes to enhance its therapeutic efficacy.

The safety profile of Cistanoside A has been evaluated in several preclinical studies, which have reported no significant adverse effects at tested doses. However, long-term studies are needed to fully assess its safety and potential side effects when used chronically or in combination with other medications.

In conclusion, Cistanoside A, with the CAS number 93236-42-1 , is a bioactive compound with diverse therapeutic potential ranging from anti-inflammatory and neuroprotective effects to anti-cancer and cardiovascular benefits. While significant progress has been made in understanding its pharmacological properties, further research is needed to optimize its extraction, enhance its bioavailability, and evaluate its long-term safety. The continued exploration of this natural product holds great promise for the development of novel therapeutic agents in various medical fields.

93236-42-1 (Cistanoside A) Related Products

Recommended suppliers
Amadis Chemical Company Limited
(CAS:93236-42-1)Cistanoside A
A1205771
Purity:99%/99%/99%
Quantity:25mg/50mg/100mg
Price ($):201.0/341.0/580.0
Email
Tiancheng Chemical (Jiangsu) Co., Ltd
(CAS:93236-42-1)肉蓯蓉苷 A
LE1695652
Purity:99%
Quantity:25KG,200KG,1000KG
Price ($):Inquiry
Email